Internal Medicine, Gastroenterology · Los Angeles, CA
NPI
1710156476
Since 2008
Specialty
Internal Medicine, Gastroenterology
Code 207RG0100X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
8631 W 3rd St, Suite 445e
Los Angeles, CA, 90048
Phone (310) 657-5244
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
17,608 services
Medicare patients, 2024
1,122
Average age 74
Drug cost, 2024
$928K
1,774 prescriptions
Company payments, 2025
$2,557
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marc D Makhani was code 99233 (hospital e&m - subsequent), 4,473 times for 449 patients. In total Marc D Makhani billed 17,608 services in 46 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-07-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 4,473 | 449 | $98.29 | $440K |
| G0316 Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 3,006 | 433 | $25.22 | $76K |
| 99443 Telephone Services | Office | 2,718 | 882 | $107.14 | $291K |
| 99214 Office E&M - Established | Office | 1,715 | 716 | $107.48 | $184K |
| 99232 Hospital E&M - Subsequent | Facility | 964 | 338 | $65.38 | $63K |
| 99497 Care Management/Coordination | Facility | 740 | 435 | $62.88 | $47K |
| 99223 Hospital E&M - Initial | Facility | 693 | 428 | $143.56 | $99K |
| 99215 Office E&M - Established | Office | 554 | 470 | $147.08 | $81K |
| G2212 Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 545 | 257 | $26.69 | $15K |
| 99497 Care Management/Coordination | Office | 506 | 479 | $67.79 | $34K |
| 99291 Critical Care E&M | Facility | 348 | 57 | $174.34 | $61K |
| 99205 Office E&M - New | Office | 302 | 302 | $176.14 | $53K |
| 43239 Upper GI Endoscopy | Facility | 254 | 242 | $66.13 | $17K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 215 | 188 | $13.82 | $2,971 |
| 45385 Colonoscopy - Lesion Removal | Facility | 102 | 97 | $207.29 | $21K |
By year: 2022 $1.7M for 16,859 services; 2023 $1.7M for 19,644 services; 2024 $1.5M for 17,608 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marc D Makhani prescribed most often to Medicare patients was Famotidine, with 212 prescriptions and refills. In total Marc D Makhani wrote 1,774 Medicare prescriptions that cost $928K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Famotidine Generic | 212 | 281 | 95 | $7,834 |
| Dicyclomine Hcl Generic | 175 | 182 | 73 | $2,210 |
| Omeprazole Generic | 135 | 183 | 63 | $880 |
| Lubiprostone Generic | 133 | 336 | 53 | $39K |
| Linzess Linaclotide | 83 | 155 | 31 | $83K |
| Omeprazole-Sodium Bicarbonate Omeprazole/Sodium Bicarbonate | 77 | 137 | 25 | $231K |
| Gavilyte-G Peg3350/Sod Sulf,bicarb,cl/Kcl | 66 | 66 | 63 | $1,011 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 61 | 61 | 57 | $3,779 |
| Colestipol Hcl Generic | 59 | 64 | 21 | $3,282 |
| Erythromycin Ethylsuccinate Generic | 55 | 140 | 31 | $35K |
| Ondansetron Hcl Generic | 54 | 54 | 19 | $302 |
| Metronidazole Generic | 46 | 46 | 44 | $290 |
| Creon Lipase/Protease/Amylase | 43 | 47 | 11 | $113K |
| Dexlansoprazole Dr Dexlansoprazole | 39 | 85 | 14 | $14K |
| Pantoprazole Sodium Generic | 33 | 67 | 16 | $394 |
Brand drugs: 398 claims; generic drugs: 1,376 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marc D Makhani $2,557 ($2,557 in general payments such as food, travel and fees) from 21 companies. The largest payer was Salix Pharmaceuticals, a division of Bausch Health US, LLC with $469.
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 32 | $469 |
| Abbvie Inc. ABBV | 15 | $346 |
| Janssen Biotech, Inc. JNJ | 10 | $314 |
| QOL Medical, LLC | 13 | $275 |
| Genzyme Corporation SNY | 8 | $223 |
| Edwards Lifesciences Corporation EW | 3 | $113 |
| Ardelyx, Inc. ARDX | 5 | $109 |
| Aimmune Therapeutics, Inc. | 4 | $99.89 |
| Pfizer Inc. PFE | 3 | $90.33 |
| Vivus LLC | 4 | $84.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.